Literature DB >> 15851011

mda-7/IL24 kills pancreatic cancer cells by inhibition of the Wnt/PI3K signaling pathways: identification of IL-20 receptor-mediated bystander activity against pancreatic cancer.

Sunil Chada1, Dora Bocangel, Rajagopal Ramesh, Elizabeth A Grimm, John B Mumm, Abner M Mhashilkar, Mingzhong Zheng.   

Abstract

The melanoma differentiation-associated gene (mda-7; approved gene symbol IL24) is a tumor suppressor gene whose protein expression in normal cells is restricted to the immune system and to melanocytes. Recent studies have shown that mda-7 gene transfer inhibits cell growth and induces apoptosis in melanoma, lung cancer, breast cancer, and other tumor types through activation of various intracellular signaling pathways. In the current study, we demonstrate that Ad-mda7 transduction of human pancreatic cancer cells results in G2/M cell cycle arrest and cell killing. Cytotoxicity is mediated via apoptosis in a time- and dose-dependent manner. Tumor cell killing correlates with regulation of proteins involved in the Wnt and PI3K pathways: beta-catenin, APC, GSK-3, JNK, and PTEN. Additionally, we identify bystander cell killing activated by exposure of pancreatic tumor cells to secreted human MDA-7 protein. In pancreatic tumor cells, exogenous MDA-7 protein activates STAT3 and kills cells via engagement of IL-20 receptors. The specificity of bystander killing is demonstrated using neutralizing anti-MDA-7 antibodies and anti-receptor antibodies, which inhibit the apoptotic effects. In sum, we show that Ad-mda7 is able to induce growth inhibition and apoptosis in pancreatic cancer cells via inhibition of the Wnt/PI3K pathways and identify a novel bystander mechanism of MDA-7 killing in pancreatic cancer that functions via IL-20 receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15851011     DOI: 10.1016/j.ymthe.2004.12.021

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  33 in total

1.  IL-2 regulates the expression of the tumor suppressor IL-24 in melanoma cells.

Authors:  Emily Y Jen; Nancy J Poindexter; Elizabeth S Farnsworth; Elizabeth A Grimm
Journal:  Melanoma Res       Date:  2012-02       Impact factor: 3.599

2.  Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant glioma.

Authors:  Hossein A Hamed; Adly Yacoub; Margaret A Park; Patrick J Eulitt; Rupesh Dash; Devanand Sarkar; Igor P Dmitriev; Maciej S Lesniak; Khalid Shah; Steven Grant; David T Curiel; Paul B Fisher; Paul Dent
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

3.  Interleukin-24 (IL24) Is Suppressed by PAX3-FOXO1 and Is a Novel Therapy for Rhabdomyosarcoma.

Authors:  Alexandra Lacey; Erik Hedrick; Yating Cheng; Kumaravel Mohankumar; Melanie Warren; Stephen Safe
Journal:  Mol Cancer Ther       Date:  2018-09-06       Impact factor: 6.261

4.  Bis-indole derived nuclear receptor 4A1 (NR4A1) antagonists inhibit TGFβ-induced invasion of embryonal rhabdomyosarcoma cells.

Authors:  Rupesh Shrestha; Kumaravel Mohankumar; Stephen Safe
Journal:  Am J Cancer Res       Date:  2020-08-01       Impact factor: 6.166

5.  Structural mapping of post-translational modifications in human interleukin-24: role of N-linked glycosylation and disulfide bonds in secretion and activity.

Authors:  Kerry L Fuson; Mingzhong Zheng; Molly Craxton; Abujiang Pataer; Rajagopal Ramesh; Sunil Chada; R Bryan Sutton
Journal:  J Biol Chem       Date:  2009-09-04       Impact factor: 5.157

Review 6.  Role of MDA-7/IL-24 a Multifunction Protein in Human Diseases.

Authors:  Mitchell E Menezes; Praveen Bhoopathi; Anjan K Pradhan; Luni Emdad; Swadesh K Das; Chunqing Guo; Xiang-Yang Wang; Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

7.  Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cells.

Authors:  Adly Yacoub; Margaret A Park; Pankaj Gupta; Mohammed Rahmani; Guo Zhang; Hossein Hamed; David Hanna; Devanand Sarkar; Irina V Lebedeva; Luni Emdad; Moira Sauane; Nicollaq Vozhilla; Sarah Spiegel; Costas Koumenis; Martin Graf; David T Curiel; Steven Grant; Paul B Fisher; Paul Dent
Journal:  Mol Cancer Ther       Date:  2008-02       Impact factor: 6.261

8.  Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of O6-methylguanine-DNA methyltransferase in human melanoma cells.

Authors:  Mingzhong Zheng; Dora Bocangel; Rajagopal Ramesh; Suhendan Ekmekcioglu; Nancy Poindexter; Elizabeth A Grimm; Sunil Chada
Journal:  Mol Cancer Ther       Date:  2008-12-03       Impact factor: 6.261

9.  IL-24 sensitizes tumor cells to TLR3-mediated apoptosis.

Authors:  R Weiss; M Sachet; J Zinngrebe; T Aschacher; M Krainer; B Hegedus; H Walczak; M Bergmann
Journal:  Cell Death Differ       Date:  2013-03-01       Impact factor: 15.828

10.  Nuclear PTEN levels and G2 progression in melanoma cells.

Authors:  Abraham I Jacob; Todd Romigh; Kristin A Waite; Charis Eng
Journal:  Melanoma Res       Date:  2009-08       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.